Dr. Roboz on Challenges With CAR T-cell Therapy in ALL – OncLive
|
Dr. Roboz on Challenges With CAR T-cell Therapy in ALL
OncLive Gail Roboz, MD, a professor of medicine and director of the Clinical and Translational Leukemia Program at Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses the challenges clinicians are facing with chimeric antigen receptor (CAR) T-cell … |
